Can Zscaler Recover From Its 34% YTD Drop?

Zscaler is still unprofitable and its revenue growth is decelerating: YoY growth slipped to 25% in Q3 FY26 and the company now guides for only 16%–17% YoY revenue growth in FY2027. Net margin was -1.6% in Q3 FY26 and the stock is down ~34% YTD as investors weigh continued losses against the AI/agent security narrative. Despite $4.6B in total current assets, guidance suggests investors may need to wait until FY2028 for a meaningful turnaround, implying further near-term downside risk.

Analysis

ZS is transitioning from a multiple story to a cash-flow story before it has earned that right, which is usually when cybersecurity names de-rate fastest. The core market mechanism is simple: if revenue growth settles in the mid-teens while losses persist, the terminal multiple compresses toward slower-growth software peers rather than premium security names. That creates a valuation gravity well for the stock unless management can show sustained billings acceleration, not just commentary about AI agents.

The second-order winner is the rest of the security basket, especially names with durable growth and clearer profitability pathways. If ZS becomes the poster child for "AI-adjacent but not AI-monetizing," capital is likely to rotate toward vendors where security spend is directly tied to platform consolidation and operating leverage. That should support relative performance in CRWD and FTNT on a 1-3 month horizon, while weakening the argument for buying every cybersecurity pullback indiscriminately.

Catalyst risk cuts both ways. A single blowout quarter could squeeze shorts because positioning is likely crowded on the bearish side after the ytd drawdown, but the burden of proof is now very high: investors will need evidence that AI-related demand is showing up in bookings, RPO, or net retention, not just pipeline language. The contrarian view is that the market may be underpricing the duration of the correction; this can remain a value trap for 6-18 months if growth deceleration proves structural and profitability only arrives via restraint rather than acceleration.

Key Decisions for Investors

• Prefer a relative-value long CRWD / short ZS pair for the next 1-3 quarters; the thesis is multiple divergence, not outright sector beta. Falsify if ZS re-accelerates growth above ~20% or shows clear booking inflection.
• If maintaining a bearish ZS view, use strength after any AI-related headline or conference move to add, rather than pressing after weak post-earnings drift. The stock can squeeze on narrative, but the fundamental path remains the cleaner short driver.
• Set a watch item on ZS next quarter for billings, RPO, and free-cash-flow margin. If revenue remains mid-teens but FCF margin inflects sharply, the short thesis weakens and the name can re-rate despite slow top-line growth.
• For sector exposure, rotate incremental capital toward FTNT over ZS on evidence that security budgets are favoring platform consolidation and operating leverage. This is a cleaner way to express the "security spend persists, but winners matter" view.